Transcriptional regulation of the NKT cell lineage

Current Opinion in Immunology

Volumn 25, Issue 2, 2013, Pages 161-167

  Constantinides, Michael G ^a   Bendelac, Albert ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLZF PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

CD4+ T LYMPHOCYTE; EFFECTOR CELL; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; THYMOCYTE; THYMUS; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINEAGE; GENE EXPRESSION REGULATION; HUMANS; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84877018173     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.01.003     Document Type: Review

References (67)

1. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., Lantz O., Bendelac A. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29:391-403.
2. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., Chua K., Eidson M., Kim H.J., Im J.S., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 2008, 9:1055-1064.
3. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
4. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nat Immunol 2010, 11:197-206.
5. Kreslavsky T., Savage A.K., Hobbs R., Gounari F., Bronson R., Pereira P., Pandolfi P.P., Bendelac A., von Boehmer H. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci USA 2009, 106:12453-12458.
6. Alonzo E.S., Gottschalk R.A., Das J., Egawa T., Hobbs R.M., Pandolfi P.P., Pereira P., Nichols K.E., Koretzky G.A., Jordan M.S., et al. Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3. J Immunol 2010, 184:1268-1279.
7. Le Bourhis L., Guerri L., Dusseaux M., Martin E., Soudais C., Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 2011, 32:212-218.
8. Kjer-Nielsen L., Patel O., Corbett A.J., Le Nours J., Meehan B., Liu L., Bhati M., Chen Z., Kostenko L., Reantragoon R., et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012, 491:717-723.
9. Bendelac A., Hunziker R.D., Lantz O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 1996, 184:1285-1293.
10. Zhou D., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.
11. Facciotti F., Ramanjaneyulu G.S., Lepore M., Sansano S., Cavallari M., Kistowska M., Forss-Petter S., Ni G., Colone A., Singhal A., et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 2012, 13:474-480.
12. Brennan P.J., Tatituri R.V., Brigl M., Kim E.Y., Tuli A., Sanderson J.P., Gadola S.D., Hsu F.F., Besra G.S., Brenner M.B. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011, 12:1202-1211.
13. Parekh V.V., Singh A.K., Wilson M.T., Olivares-Villagomez D., Bezbradica J.S., Inazawa H., Ehara H., Sakai T., Serizawa I., Wu L., et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids. J Immunol 2004, 173:3693-3706.
14. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J Exp Med 1995, 182:2091-2096.
15. Hu T., Gimferrer I., Simmons A., Wiest D., Alberola-Ila J. The Ras/MAPK pathway is required for generation of iNKT cells. PLoS ONE 2011, 6:e19890.
16. Lazarevic V., Zullo A.J., Schweitzer M.N., Staton T.L., Gallo E.M., Crabtree G.R., Glimcher L.H. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol 2009, 10:306-313.
17. Seiler M.P., Mathew R., Liszewski M.K., Spooner C., Barr K., Meng F., Singh H., Bendelac A. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 2012, 13:264-271.
18. Moran A.E., Holzapfel K.L., Xing Y., Cunningham N.R., Maltzman J.S., Punt J., Hogquist K.A. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 2011, 208:1279-1289.
19. Graham D.B., Bell M.P., Huntoon C.J., Griffin M.D., Tai X., Singer A., McKean D.J. CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling. J Immunol 2006, 177:6098-6107.
20. Williams J.A., Lumsden J.M., Yu X., Feigenbaum L., Zhang J., Steinberg S.M., Hodes R.J. Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway. J Immunol 2008, 181:907-917.
21. Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G., Mamchak A.A., Terhorst C., Bendelac A. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007, 27:751-762.
22. Qiao Y., Zhu L., Sofi H., Lapinski P.E., Horai R., Mueller K., Stritesky G.L., He X., Teh H.S., Wiest D.L., et al. Development of promyelocytic leukemia zinc finger-expressing innate CD4 T cells requires stronger T-cell receptor signals than conventional CD4 T cells. Proc Natl Acad Sci USA 2012, 109:16264-16269.
23. Savage A.K., Constantinides M.G., Bendelac A. Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling. J Immunol 2011, 186:5801-5806.
24. Kovalovsky D., Alonzo E.S., Uche O.U., Eidson M., Nichols K.E., Sant'Angelo D.B. PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals. J Immunol 2010, 184:6746-6755.
25. Thomas S.Y., Scanlon S.T., Griewank K.G., Constantinides M.G., Savage A.K., Barr K.A., Meng F., Luster A.D., Bendelac A. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 2011, 208:1179-1188.
26. Mathew R., Seiler M.P., Scanlon S.T., Mao A.P., Constantinides M.G., Bertozzi-Villa C., Singer J.D., Bendelac A BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature 2012, 491:618-621.
27. McNab F.W., Berzins S.P., Pellicci D.G., Kyparissoudis K., Field K., Smyth M.J., Godfrey D.I. The influence of CD1d in postselection NKT cell maturation and homeostasis. J Immunol 2005, 175:3762-3768.
28. Wei D.G., Curran S.A., Savage P.B., Teyton L., Bendelac A. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition. J Exp Med 2006, 203:1197-1207.
29. Benlagha K., Kyin T., Beavis A., Teyton L., Bendelac A. A thymic precursor to the NKT cell lineage. Science 2002, 296:553-555.
30. Yoshimoto T., Paul W.E. CD4pos NK1.1pos T cells promptly produced IL-4 in response to in vivo challenge with anti-CD3. J Exp Med 1994, 179:1285.
31. Terashima A., Watarai H., Inoue S., Sekine E., Nakagawa R., Hase K., Iwamura C., Nakajima H., Nakayama T., Taniguchi M. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008, 205:2727-2733.
32. Watarai H., Sekine-Kondo E., Shigeura T., Motomura Y., Yasuda T., Satoh R., Yoshida H., Kubo M., Kawamoto H., Koseki H., et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 2012, 10:e1001255.
33. Doisne J.M., Becourt C., Amniai L., Duarte N., Le Luduec J.B., Eberl G., Benlagha K. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J Immunol 2009, 183:2142-2149.
34. Coquet J.M., Chakravarti S., Kyparissoudis K., McNab F.W., Pitt L.A., McKenzie B.S., Berzins S.P., Smyth M.J., Godfrey D.I. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci USA 2008, 105:11287-11292.
35. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., Wong C.H., Schneider E., Dy M., Leite-de-Moraes M.C. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204:995-1001.
36. Matsuda J.L., Gapin L., Sidobre S., Kieper W.C., Tan J.T., Ceredig R., Surh C.D., Kronenberg M. Homeostasis of V alpha 14i NKT cells. Nat Immunol 2002, 3:966-974.
37. Milpied P., Massot B., Renand A., Diem S., Herbelin A., Leite-de-Moraes M., Rubio M.T., Hermine O. IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 2011, 118:2993-3002.
38. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., Gapin L., Glimcher L.H. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004, 20:477-494.
39. van Gisbergen K.P., Kragten N.A., Hertoghs K.M., Wensveen F.M., Jonjic S., Hamann J., Nolte M.A., van Lier R.A. Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation. Nat Immunol 2012, 13:864-871.
40. Bezbradica J.S., Hill T., Stanic A.K., Van Kaer L., Joyce S. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc Natl Acad Sci USA 2005, 102:5114-5119.
41. Guo J., Hawwari A., Li H., Sun Z., Mahanta S.K., Littman D.R., Krangel M.S., He Y.W. Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes. Nat Immunol 2002, 3:469-476.
42. Kim P.J., Pai S.Y., Brigl M., Besra G.S., Gumperz J., Ho I.C. GATA-3 regulates the development and function of invariant NKT cells. J Immunol 2006, 177:6650-6659.
43. Wang L., Carr T., Xiong Y., Wildt K.F., Zhu J., Feigenbaum L., Bendelac A., Bosselut R. The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol 2010, 40:2385-2390.
44. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., Gantner B.N., Dinner A.R., Singh H. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126:755-766.
45. Kaplan M.H., Wurster A.L., Smiley S.T., Grusby M.J. Stat6-dependent and -independent pathways for IL-4 production. J Immunol 1999, 163:6536-6540.
46. Stetson D.B., Mohrs M., Reinhardt R.L., Baron J.L., Wang Z.E., Gapin L., Kronenberg M., Locksley R.M. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003, 198:1069-1076.
47. Weinreich M.A., Odumade O.A., Jameson S.C., Hogquist K.A. T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells. Nat Immunol 2010, 11:709-716.
48. Weinreich M.A., Takada K., Skon C., Reiner S.L., Jameson S.C., Hogquist K.A. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 2009, 31:122-130.
49. Odumade O.A., Weinreich M.A., Jameson S.C., Hogquist K.A. Kruppel-like factor 2 regulates trafficking and homeostasis of gammadelta T cells. J Immunol 2010, 184:6060-6066.
50. Atherly L.O., Lucas J.A., Felices M., Yin C.C., Reiner S.L., Berg L.J. The tec family tyrosine kinases itk and rlk regulate the development of conventional CD8(+) T cells. Immunity 2006, 25:79-91.
51. Broussard C., Fleischecker C., Horai R., Chetana M., Venegas A.M., Sharp L.L., Hedrick S.M., Fowlkes B.J., Schwartzberg P.L. Altered development of CD8(+) T cell lineages in mice deficient for the tec kinases itk and rlk. Immunity 2006, 25:93-104.
52. Verykokakis M., Boos M.D., Bendelac A., Adams E.J., Pereira P., Kee B.L. Inhibitor of DNA binding 3 limits development of murine slam-associated adaptor protein-dependent "innate" gammadelta T cells. PLoS ONE 2010, 5:e9303.
53. Verykokakis M., Boos M.D., Bendelac A., Kee B.L. SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics. Immunity 2010, 33:203-215.
54. Fukuyama T., Kasper L.H., Boussouar F., Jeevan T., van Deursen J., Brindle P.K. Histone acetyltransferase CBP is vital to demarcate conventional and innate CD8+ T-cell development. Mol Cell Biol 2009, 29:3894-3904.
55. Lai D., Zhu J., Wang T., Hu-Li J., Terabe M., Berzofsky J.A., Clayberger C., Krensky A.M. KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. J Exp Med 2011, 208:1093-1103.
56. Enders A., Stankovic S., Teh C., Uldrich A.P., Yabas M., Juelich T., Altin J.A., Frankenreiter S., Bergmann H., Roots C.M., et al. ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells. J Immunol 2012, 189:5240-5249.
57. Engel I., Zhao M., Kappes D., Taniuchi I., Kronenberg M. The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cells. Blood 2012, 120:4524-4532.
58. Chang P.P., Barral P., Fitch J., Pratama A., Ma C.S., Kallies A., Hogan J.J., Cerundolo V., Tangye S.G., Bittman R., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol 2012, 13:35-43.
59. King I.L., Fortier A., Tighe M., Dibble J., Watts G.F., Veerapen N., Haberman A.M., Besra G.S., Mohrs M., Brenner M.B., et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 2012, 13:44-50.
60. Monteiro M., Almeida C.F., Caridade M., Ribot J.C., Duarte J., Agua-Doce A., Wollenberg I., Silva-Santos B., Graca L. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol 2010, 185:2157-2163.
61. Moreira-Teixeira L., Resende M., Devergne O., Herbeuval J.P., Hermine O., Schneider E., Dy M., Cordeiro-da-Silva A., Leite-de-Moraes M.C. Rapamycin combined with TGF-beta converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J Immunol 2012, 188:624-631.
62. Finlay D.K., Kelly A.P., Clarke R., Sinclair L.V., Deak M., Alessi D.R., Cantrell D.A. Temporal differences in the dependency on phosphoinositide-dependent kinase 1 distinguish the development of invariant Valpha14 NKT cells and conventional T cells. J Immunol 2010, 185:5973-5982.
63. Dose M., Sleckman B.P., Han J., Bredemeyer A.L., Bendelac A., Gounari F. Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc Natl Acad Sci USA 2009, 106:8641-8646.
64. Mycko M.P., Ferrero I., Wilson A., Jiang W., Bianchi T., Trumpp A., MacDonald H.R. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development. J Immunol 2009, 182:4641-4648.
65. Yang K., Neale G., Green D.R., He W., Chi H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat Immunol 2011, 12:888-897.
66. Powell J.D., Pollizzi K.N., Heikamp E.B., Horton M.R. Regulation of immune responses by mTOR. Annu Rev Immunol 2012, 30:39-68.
67. Allende M.L., Zhou D., Kalkofen D.N., Benhamed S., Tuymetova G., Borowski C., Bendelac A., Proia R.L. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J 2008, 22:307-315.